相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。N-acylethanolamine acid amidase (NAAA) inhibition decreases the motivation for alcohol in Marchigian Sardinian alcohol-preferring rats
Yannick Fotio et al.
PSYCHOPHARMACOLOGY (2021)
N-acylethanolamine-hydrolysing acid amidase: A new potential target to treat paclitaxel-induced neuropathy
Wisam Toma et al.
EUROPEAN JOURNAL OF PAIN (2021)
N-Acylethanolamine Acid Amidase (NAAA): Structure, Function, and Inhibition
Daniele Piomelli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
N-Acylethanolamine Acid Amidase (NAAA): Mechanism of Palmitoylethanolamide Hydrolysis Revealed by Mechanistic Simulations
Laura Scalvini et al.
ACS CATALYSIS (2020)
N-Acylethanolamine acid amidase (NAAA) inhibitor F215 as a novel therapeutic agent for osteoarthritis
Pan Zhou et al.
PHARMACOLOGICAL RESEARCH (2019)
Efficacy of a Combination of N-Palmitoylethanolamide, Beta-Caryophyllene, Carnosic Acid, and Myrrh Extract on Chronic Neuropathic Pain: A Preclinical Study
Yannick Fotio et al.
FRONTIERS IN PHARMACOLOGY (2019)
Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward
Claudia Sagheddu et al.
NEUROPHARMACOLOGY (2019)
Gabapentin for Chronic Neuropathic Pain
Andrew Moore et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis
Marco Migliore et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy
Linda Gabrielsson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
An Important Role for N-Acylethanolamine Acid Amidase in the Complete Freund's Adjuvant Rat Model of Arthritis
F. T. Bonezzi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
The anti-inflammatory effects of palmitoylethanolamide (PEA) on endotoxin-induced uveitis in rats
Daniela Impellizzeri et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis
Mireille Alhouayek et al.
FASEB JOURNAL (2015)
Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent
Francesca Borrelli et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
A Lipid Gate for the Peripheral Control of Pain
Daniele Piomelli et al.
JOURNAL OF NEUROSCIENCE (2014)
Peripheral gating of pain signals by endogenous lipid mediators
Daniele Piomelli et al.
NATURE NEUROSCIENCE (2014)
Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models
Oscar Sasso et al.
PAIN (2013)
A fatty gut feeling
Daniele Piomelli
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2013)
Peroxisome Proliferator-Activated Receptor α Mediates Acute Effects of Palmitoylethanolamide on Sensory Neurons
Iryna A. Khasabova et al.
JOURNAL OF NEUROSCIENCE (2012)
OPINION Sex differences in pain and pain inhibition: multiple explanations of a controversial phenomenon
Jeffrey S. Mogil
NATURE REVIEWS NEUROSCIENCE (2012)
Ulcerative Colitis Impairs the Acylethanolamide-Based Anti-Inflammatory System Reversal by 5-Aminosalicylic Acid and Glucocorticoids
Juan Suarez et al.
PLOS ONE (2012)
Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation
Carlos Solorzano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Receptors for acylethanolamides-GPR55 and GPR119
Grzegorz Godlewski et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2009)
Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis
Denise Richardson et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain
Margarita Suardiaz et al.
PAIN (2007)
Explaining the escalation of drug use in substance dependence: Models and appropriate animal laboratory tests
Gerald Zernig et al.
PHARMACOLOGY (2007)
Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-α
Jesse LoVerme et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Oleoylethanolamide, an endogenous PPAR-α agonist, lowers body weight and hyperlipidemia in obese rats
J Fu et al.
NEUROPHARMACOLOGY (2005)
Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase
K Tsuboi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide
J Lo Verme et al.
MOLECULAR PHARMACOLOGY (2005)
Molecular characterization of a phospholipase D generating anandamide and its congeners
Y Okamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Activation of TRPV1 by the satiety factor oleoylethanolamide
GP Ahern
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel
RC Polomano et al.
PAIN (2001)
Chemotherapy-evoked painful peripheral neuropathy
RC Polomano et al.
PAIN MEDICINE (2001)
分享论文
